KRKA UKRAINE, LLC
Krka is one of the world's leading generic pharmaceutical companies. Its registered office is in Slovenia. Krka has over 60 years of experience in the industry. It is engaged in the development, production, sale and marketing of human health products (prescription pharmaceuticals and non-prescription products), animal health products and health resort and tourist services.
Krka focus on generic prescription pharmaceuticals marketed under its own brands. Main therapeutic groups include pharmaceuticals for cardiovascular diseases, alimentary and metabolic diseases and for the central nervous system. Company has been entering new therapeutic areas (oncology medicines, anti-virus medicines), and in selected areas also with non-prescription products. It has more than 170 new products in the pipeline. A large share of revenue is generated by sales of new products, i.e. products launched in different markets in the past five years.
Krka is the leader in the Slovenian market and significantly present in the generic pharmaceutical markets of Eastern, Central and South-Eastern Europe, and in the markets of Western Europe. It has been strengthening also presence in overseas markets (Middle East, Far East, Africa and the Americas).
Production takes place in Slovenia, Poland, the Russian Federation, Croatia and Germany, while the remaining subsidiaries outside Slovenia are engaged in the marketing and/or sale of Krka products.